BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scelfo C, Menzella F, Fontana M, Ghidoni G, Galeone C, Facciolongo NC. Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance. Vaccines (Basel) 2021;9:420. [PMID: 33922273 DOI: 10.3390/vaccines9050420] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu T, Miller DF, Taylor AW, Riley C, Mccormick C, Thomas KN, Gao RY, Rowlen KL, Byrne EB, Kumar P, Kim SK, Dawson ED. 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization. Vaccines 2022;10:1964. [DOI: 10.3390/vaccines10111964] [Reference Citation Analysis]
2 Ryman J, Weaver J, Hu T, Weinberger DM, Yee KL, Sachs JR. Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data. npj Vaccines 2022;7:140. [DOI: 10.1038/s41541-022-00538-1] [Reference Citation Analysis]
3 Ryman J, Weaver J, Yee KL, Sachs JR. Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children. Expert Rev Vaccines 2022;:1-7. [PMID: 35997125 DOI: 10.1080/14760584.2022.2112179] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Adamu AL, Ojal J, Abubakar IA, Odeyemi K, Bello MM, Okoromah CA, Karia B, Karani A, Akech D, Inem V, Scott JAG, Adetifa IM. The impact of introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) on pneumococcal carriage in Nigeria.. [DOI: 10.1101/2022.03.11.22271682] [Reference Citation Analysis]
5 Vale FF, Tanoeiro L, Marques AT. 16S Genomics for Diagnosing Invasive Bacterial Infection. Encyclopedia of Infection and Immunity 2022. [DOI: 10.1016/b978-0-12-818731-9.00213-5] [Reference Citation Analysis]
6 Subramanian R, Liyanapathirana V, Barua N, Sun R, Wang MH, Ng R, Nelson EAS, Hui DS, Ip M. Persistence of Pneumococcal Serotype 3 in Adult Pneumococcal Disease in Hong Kong. Vaccines (Basel) 2021;9:756. [PMID: 34358172 DOI: 10.3390/vaccines9070756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]